发明授权
US08476023B2 Methods relating to aromatase inhibitor pharmacogenetics 失效
涉及芳香酶抑制剂药物遗传学的方法

Methods relating to aromatase inhibitor pharmacogenetics
摘要:
Methods for aiding in determining therapeutic efficacy of an aromatase inhibitor in a subject are provided according to embodiments of the present invention which include detecting expression and/or function of at least one UDP-glucuronosyltransferase having activity to modify at least one aromatase inhibitor and/or metabolite of the aromatase inhibitor by glucuronidation, wherein detection of expression and/or function of the UDP-glucuronosyltransferase is correlated with therapeutic efficacy of the aromatase inhibitor in the subject. Detection of UDP-glucuronosyltransferase expression and/or function includes detection of a UDP-glucuronosyltransferase gene deletion polymorphism in the subject.
公开/授权文献
信息查询
0/0